Search for: "Gray v. Myers" Results 21 - 40 of 41
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jul 2012, 10:46 pm by tekEditor
That view seems to push back against most of the decisions listed above, like CyberSource and Prometheus, notes Jim Myers, a Ropes & Gray partner whose patent practice involves mostly defending financial institutions against patent assertions. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
26 Jul 2008, 5:38 pm
Process:  Lee Jay Berman standing; left to right:  Joan Kessler, Jim Lingl and Therese GrayJim Lingl can resolve most disputes with the proper process but when disputes involve people outside the room, need substantive knowledge Joan Kessler any mediator can handle any type of dispute legal issues important in litigated cases she's evaluative she gives bad news to both sides in separate caucus she's a former jury consultant Therese… [read post]
10 Nov 2010, 2:41 pm by Kara OBrien
  The members of the panel are Keith Higgins of Ropes & Gray, Mark Borges of Compensia, Martin Dunn of O’Melveny & Myers, Amy Goodman of Gibson Dunn, David Lynn of Morrison & Foerster and Meredith Cross of the SEC. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
23 May 2013, 10:06 am by Dan Markel
Levine) Jenia Iontcheva Turner – Effective Remedies for Ineffective Assistance of Counsel: A New Look After Lafler v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), Domain name transfer made easier: (Australian Trade Marks Law Blog), Quantum of obviousness in Australian patent laws - C Lawson: (IP Down Under), Separating Sony sheep from Grokster (and Kazaa) goats: Reckoning [read post]
11 Apr 2011, 5:14 am by Rebecca Tushnet
Many students of games have dismissed this because of gray markets, other interpenetration between gamespace and elsewhere. [read post]